Skip to main content
. 2022 Jul 7;13:952982. doi: 10.3389/fmicb.2022.952982

Table 3.

Phenotypic and genotypic analyses of antimicrobial resistance of P. mirabilis isolates.

Antimicrobial drugs Coherent results Incoherent results Percentage of coherence
Species Name Both susceptible Both resistant Phenotype resistance and genotype susceptible Phenotype susceptible and genotype resistance
Tetracyclines
Tetracycline 0 30 0 0 100.00% (30/30)
Minocycline 0 30 0 0 100.00% (30/30)
Fluoroquinolones
Ofloxacin 0 21 0 9 70.00% (21/30)
Naphthaleneic acid 0 22 0 8 73.33% (22/30)
Ciprofloxacin 0 23 0 7 76.67% (23/30)
Macrolide
Azithromycin 0 30 0 0 100.00% (30/30)
Erythromycin 0 30 0 0 100.00% (30/30)
β-Lactam combination
Ampicillin 3 17 9 0 70.00% (21/30)
Amoxicillin/clavulanic acid 3 17 9 0 70.00% (21/30)
Ceftiofur 3 20 5 2 76.67% (23/30)
Meropenem 4 14 4 8 60.00% (18/30)
Aminoglycosides
Amikacin 10 9 0 11 63.33% (19/30)
Gentamicin 6 17 4 3 76.67% (23/30)
Phenicols
Chloramphenicol 0 30 0 0 100.00% (30/30)
Rifamycin
Rifamycin 0 19 3 8 63.33% (19/30)